Loading company…
Voluntis develops digital therapeutics with personalized, algorithm-driven support for patients and care teams.
Voluntis develops digital therapeutics that provide personalized, algorithm-driven support for patients and care teams. Its Theraxium platform supports therapies in oncology and chronic diseases and has regulatory clearances in the United States, Canada, and Europe. Founded in 2001, the company is based in Suresnes, France. In September 2021, it raised EUR 10.375 mn in a Series C round led by Bpifrance Investissement.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in